Cyclin D1 and associated proteins in mammary ductal carcinoma in situ and atypical ductal hyperplasia

Journal of Pathology

Volumn 184, Issue 4, 1998, Pages 396-400

  Gillett, Cheryl E ^a   Lee, Andrew H S ^a   Millis, Rosemary R ^a   Barnes, Diana M ^a  

^a GUY S HOSPITAL   (United Kingdom)

Author keywords

ADH; Breast cancer; Cyclin D1; DCIS; Immunohistochemistry; Oestrogen receptor; Retinoblastoma protein

Indexed keywords

CYCLIN D1; ESTROGEN RECEPTOR; RETINOBLASTOMA PROTEIN;

ARTICLE; BREAST CANCER; BREAST DUCT; BREAST HYPERPLASIA; CANCER INVASION; CARCINOMA IN SITU; CELL DIFFERENTIATION; FEEDBACK SYSTEM; GENE AMPLIFICATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MULTIGENE FAMILY; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAINING;

ADULT; AGED; AGED, 80 AND OVER; BREAST; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; CYCLIN D1; FEMALE; HUMANS; HYPERPLASIA; IMMUNOENZYME TECHNIQUES; MIDDLE AGED; NEOPLASM PROTEINS; PRECANCEROUS CONDITIONS; RECEPTORS, ESTROGEN; RETINOBLASTOMA PROTEIN;

EID: 0031941201     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199804)184:4<396::AID-PATH1259>3.0.CO;2-G     Document Type: Article

References (18)

1. Müller H, Lukas J, Schneider A, et al. Cyclin DI expression is regulated by the retinoblastoma protein. Proc Natl Acad Sci USA 1994; 91: 2945-2949.
2. Zetterberg A, Larsson O, Wiman KG. What is the restriction point? Curr Opin Cell Biol 1995; 7: 835-842.
3. Fantl V, Smith R, Brookes S, Dickson C, Peters G. Chromosome 11q13 abnormalities in human breast cancer. Cancer Surv 1993; 18: 77-94.
4. Gillett C, Fantl V, Smith R, et al. Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res 1994; 54: 1812-1817.
5. Bartkova J, Lukas J, Strauss M, Bartek J. Cyclin D1 oncoprotein aberrantly accumulates in malignancies of diverse histogenesis. Oncogene 1995; 10: 775-778.
6. Gillett C, Smith P, Gregory W, et al. Cyclin D1 and prognosis in human breast cancer. Int J Cancer (Pred Oncol) 1996; 69: 92-99.
7. Nielson NH, Emdin SO, Landberg G. Deregulation of G1 cyclins and pRb alterations in estrogen receptor negative breast cancer with poor prognosis. Proc Am Assoc Cancer Res 1996; 37: 4.
8. Dublin EA, Patel NK, Gillett CE, et al. Retinoblastoma and p16 proteins in mammary carcinoma: their relationship to cyclin D1 and histopathological parameters. Int J Cancer 1998; (in press).
9. Pietiläinen T, Lipponen P, Aaltomaa S, Eskelinen M, Kosma V-M, Syrjänen K. Expression of retinoblastoma gene protein (Rb) in breast cancer as related to established prognostic factors and survival. Eur J Cancer 1995; 31A: 329-333.
10. Weinstat-Saslow D, Merino MJ, Manrow RE, et al. Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesions. Nature (Med) 1995; 1: 1257-1260.
11. Holland R, Peterse JL, Millis RR, et al. Ductal carcinoma in situ: a proposal for a new classification. Semin Diagn Pathol 1994; 11: 167-180.
12. Page DL, Rogers LW. Combined histologic and cytologic criteria for the diagnosis of mammary atypical ductal hyperplasia. Hum Pathol 1992; 23: 1095-1097.
13. Barnes DM, Harris WH, Smith P, Millis RR, Rubens RD. Immunohistochemical determination of oestrogen receptors: comparison of different methods of assessment of staining and correlation with clinical outcome of breast cancer patients. Br J Cancer 1996; 74: 1445-1451.
14. McIntosh GG, Anderson JJ, Milton I, et al. Determination of the prognostic value of cyclin D1 overexpression in breast cancer. Oncogene 1995; 11: 885-891.
15. Michalides R, Hageman P, van Tineren H, et al. A clinicopathological study on overexpression of cyclin D1 and of p53 in a series of 248 patients with operable breast cancer. Br J Cancer 1996; 73: 728-734.
16. Barnes DM. c-erbB-2 amplification in mammary carcinoma. J Cell Biochem 1993; 17G: 132-138.
17. Fantl V, Richards MA, Smith R, et al. Gene amplification on chromosome band 11q13 and oestrogen receptor status in breast cancer. Eur J Cancer 1990; 26: 423-429.
18. Millis RR, Bobrow LG, Barnes DM. Immunohistochemical evaluation of biological markers in mammary carcinoma in situ: correlation with morphological features and recently proposed schemes for histological classification. Breast 1996; 5: 113-122.